Thrombus characterisation and evolution of hypoattenuating leaflet thickening after transcatheter aortic valve

Kajetan Grodecki1,2, Damini Dey1, Jolien Geers1,3

  • 1Departments of Biomedical Sciences and Medicine, Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Insights

Quantitative computed tomography angiography (CTA) analysis of hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) predicts HALT resolution and correlates with valve function. This aids in guiding oral anticoagulation therapy decisions.

Area of Science:

  • Cardiology
  • Radiology
  • Biomedical Engineering

Background:

  • Hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) requires further understanding for clinical management.
  • Computed tomography angiography (CTA) offers a potential imaging modality for quantifying HALT and its implications.

Purpose of the Study:

  • To assess the association between quantitative CTA features of HALT and its temporal evolution post-TAVI.
  • To evaluate predictors of HALT resolution and progression in a real-world cohort.

Main Methods:

  • CTA analysis of 612 patients 30 days post-TAVI with balloon-expandable bioprostheses.
  • Prospective follow-up CTA at 1 year for 99 patients to assess HALT progression.
  • Quantitative assessment of thrombus volume, mean attenuation, and bioprosthetic deformation parameters.

Main Results:

  • HALT was detected in 19% of patients; complete resolution occurred in 43 patients.
  • Lower thrombus attenuation, eccentricity index, deformation index, and implant canting predicted HALT resolution.
  • Thrombus volume changes correlated with changes in transvalvular gradients, indicating impact on valve hemodynamics.

Conclusions:

  • Quantitative CTA characterization of HALT predicts its resolution after TAVI.
  • HALT evolution on CTA correlates with the hemodynamic performance of transcatheter aortic valves.
  • CTA-based quantitative thrombus assessment may inform oral anticoagulation therapy decisions post-TAVI.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
834
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
470